Literature DB >> 10348311

Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.

T Araki1, H Tanji, K Fujihara, H Kato, Y Itoyama.   

Abstract

Receptor autoradiographic technique was studied to investigate sequential changes in FK-506 binding proteins, nitric oxide synthase and dopamine uptake sites in the brain 1 week to 8 weeks after unilateral 6-hydroxydopamine injection of the medial forebrain bundle in rats. [3H]FK-506, [3H]L-N(G)-nitro-arginine and [3H]mazindol were used to label FK-506 binding proteins (immunophilin), nitric oxide synthase and dopamine uptake sites, respectively. [3H]FK-506 binding showed about 13-25% increase in the ipsilateral striatum from 2 to 8 weeks after degeneration of nigrostriatal pathway. However, no significant change in [3H]FK-506 binding was observed in the ipsilateral substantia nigra during the postlesion periods. In the contralateral side, [3H]FK-506 binding also showed about 13-25% increase in the striatum from 2 to 8 weeks postlesion. The substantia nigra showed a 21% increase in [3H]FK-506 binding only 2 weeks after the lesioning. On the other hand, [3H]L-N(G)-nitro-arginine binding showed about 21-31% increase in the parietal cortex and striatum 1 week or 2 weeks postlesion. In the contralateral side, a 21% increase in [3H]L-N(G)-nitro-arginine binding was found in the dorsolateral striatum only 1 week postlesion. In contrast, degeneration of nigrostriatal pathway caused a conspicuous loss of [3H]mazindol binding in the ipsilateral striatum (87-96%), substantia nigra (36-73%) and ventral tegmental area (91-100%) during the postlesion periods. In the contralateral side, no significant changes in [3H]mazindol binding were observed in these areas up to 8 weeks after the postlesion. The present study demonstrates that unilateral injection of 6-hydroxydopamine into the medial forebrain bundle of rats can cause a significant increase in [3H]FK-506 and [3H]L-N(G)-nitro-arginine bindings in the brains. In contrast, a marked reduction in [3H]mazindol binding is observed in the brains after the lesioning, indicating severe damage to nigrostriatal dopaminergic pathway. These results suggest that immunophilin and nitric oxide synthase may play some role in the pathogenesis of neurodegenerative disorders such as Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348311     DOI: 10.1023/a:1020605429535

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  33 in total

1.  High brain densities of the immunophilin FKBP colocalized with calcineurin.

Authors:  J P Steiner; T M Dawson; M Fotuhi; C E Glatt; A M Snowman; N Cohen; S H Snyder
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

2.  Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse.

Authors:  J P Nowicki; D Duval; H Poignet; B Scatton
Journal:  Eur J Pharmacol       Date:  1991-11-12       Impact factor: 4.432

3.  Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.

Authors:  J Sharkey; S P Butcher
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

4.  Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.

Authors:  J M Saavedra; P E Setler; J W Kebabian
Journal:  Brain Res       Date:  1978-08-04       Impact factor: 3.252

5.  Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine.

Authors:  Z Huang; P L Huang; J Ma; W Meng; C Ayata; M C Fishman; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

6.  Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil.

Authors:  T Tokime; K Nozaki; H Kikuchi
Journal:  Neurosci Lett       Date:  1996-03-15       Impact factor: 3.046

7.  Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart.

Authors:  Y Nishinaka; S Sugiyama; M Yokota; H Saito; T Ozawa
Journal:  J Cardiovasc Pharmacol       Date:  1993-03       Impact factor: 3.105

8.  Postischemic alteration of [3H]forskolin binding sites in selectively vulnerable areas: an autoradiographic study of gerbil brain.

Authors:  T Araki; H Kato; H Hara; K Kogure
Journal:  Neurosci Lett       Date:  1991-04-29       Impact factor: 3.046

9.  Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice.

Authors:  Y Kitamura; Y Itano; T Kubo; Y Nomura
Journal:  J Neuroimmunol       Date:  1994-03       Impact factor: 3.478

10.  Blockade of nitric oxide formation by N omega-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats.

Authors:  T Nagafuji; T Matsui; T Koide; T Asano
Journal:  Neurosci Lett       Date:  1992-12-07       Impact factor: 3.046

View more
  6 in total

1.  Damage to neurons and oligodendrocytes in the hippocampal CA1 sector after transient focal ischemia in rats.

Authors:  Hiroto Uchida; Yuki Fujita; Misato Matsueda; Masahiro Umeda; Shunsuke Matsuda; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2010-07-13       Impact factor: 5.046

2.  Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.

Authors:  Y Muramatsu; R Kurosaki; T Mikami; M Michimata; M Matsubara; Y Imai; H Kato; Y Itoyama; T Araki
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

3.  Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Sho Takagi; Yu Watanabe; Hiroyuki Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-01-31       Impact factor: 3.575

Review 4.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Authors:  Hironori Yokoyama; Hayato Kuroiwa; Ryohei Yano; Tsutomu Araki
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

5.  Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Ryohei Yano; Eriko Aoki; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

6.  Arsenic affects inflammatory cytokine expression in Gallus gallus brain tissues.

Authors:  Xiao Sun; Ying He; Ying Guo; Siwen Li; Hongjing Zhao; Yu Wang; Jingyu Zhang; Mingwei Xing
Journal:  BMC Vet Res       Date:  2017-06-05       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.